×
Join our live online event
How top hedge funds use news to make money
form the stock market & how ordinary people are
copying their strategies
Register now!
form the stock market & how ordinary people are
copying their strategies
No thanks
INAB – in8bio, inc. (US:NASDAQ)
DELAYED
$
| Volume Shares | |
| 1 Day Range | |
| Volume Ratio | |
| 52 Week High | |
| 52 Week Low |
| VWAP | |
| Today’s Volatility | |
| 20 Days Volatility | |
| Open | |
| Prior Close |
1D
5D
1M
3M
YTD
1Y
3Y
1 Day
INAB
SPY
QQQ
Swipe to see more
Main News & Impact Reports
Date
Time
Symbol
Headline
Impact
12/10
07:07 am
inab
IN8bio Reports Continued Progression-Free Survival in Phase 1 Investigator-Sponsored Trial of INB-100 Allogeneic Gamma-Delta T Cells for Leukemias at the 2024 American Society of Hematology Annual Meeting [Yahoo! Finance]
Medium
Report
IN8bio Reports Continued Progression-Free Survival in Phase 1 Investigator-Sponsored Trial of INB-100 Allogeneic Gamma-Delta T Cells for Leukemias at the 2024 American Society of Hematology Annual Meeting [Yahoo! Finance]
12/10
07:00 am
inab
IN8bio Reports Continued Progression-Free Survival in Phase 1 Investigator-Sponsored Trial of INB-100 Allogeneic Gamma-Delta T Cells for Leukemias at the 2024 American Society of Hematology Annual Meeting
High
Report
IN8bio Reports Continued Progression-Free Survival in Phase 1 Investigator-Sponsored Trial of INB-100 Allogeneic Gamma-Delta T Cells for Leukemias at the 2024 American Society of Hematology Annual Meeting
12/2
07:00 am
inab
IN8bio to Present at Noble Capital Markets' Twentieth Annual Emerging Growth Equity Conference
High
Report
IN8bio to Present at Noble Capital Markets' Twentieth Annual Emerging Growth Equity Conference
11/26
08:00 am
inab
IN8bio, Inc. (NASDAQ: INAB) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $8.00 price target on the stock.
Medium
Report
IN8bio, Inc. (NASDAQ: INAB) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $8.00 price target on the stock.
11/25
07:19 am
inab
IN8bio Reports Continued Durable Remissions in Phase 1 Trial of INB-200 in Plenary Oral Presentation at the Society for Neuro-Oncology (SNO) Annual Meeting [Yahoo! Finance]
Medium
Report
IN8bio Reports Continued Durable Remissions in Phase 1 Trial of INB-200 in Plenary Oral Presentation at the Society for Neuro-Oncology (SNO) Annual Meeting [Yahoo! Finance]
11/25
07:00 am
inab
IN8bio Reports Continued Durable Remissions in Phase 1 Trial of INB-200 in Plenary Oral Presentation at the Society for Neuro-Oncology (SNO) Annual Meeting
Medium
Report
IN8bio Reports Continued Durable Remissions in Phase 1 Trial of INB-200 in Plenary Oral Presentation at the Society for Neuro-Oncology (SNO) Annual Meeting
11/13
09:10 am
inab
IN8bio, Inc. (NASDAQ: INAB) had its price target lowered by analysts at HC Wainwright from $12.50 to $8.00. They now have a "buy" rating on the stock.
Medium
Report
IN8bio, Inc. (NASDAQ: INAB) had its price target lowered by analysts at HC Wainwright from $12.50 to $8.00. They now have a "buy" rating on the stock.
11/12
04:30 pm
inab
IN8bio Reports Third Quarter 2024 Financial Results and Recent Corporate Highlights [Yahoo! Finance]
Medium
Report
IN8bio Reports Third Quarter 2024 Financial Results and Recent Corporate Highlights [Yahoo! Finance]
Date
Time
Action
From
To
Firm
Impact
%Chg
Date
Time
Symbol
Headline
Impact
12/23
04:15 pm
inab
Form 4 IN8BIO, INC. For: Dec 19 Filed by: Roemer Alan S.
Low
Report
Form 4 IN8BIO, INC. For: Dec 19 Filed by: Roemer Alan S.
12/23
04:15 pm
inab
Form 4 IN8BIO, INC. For: Dec 19 Filed by: Whitfill Travis
Low
Report
Form 4 IN8BIO, INC. For: Dec 19 Filed by: Whitfill Travis
12/23
04:15 pm
inab
Form 4 IN8BIO, INC. For: Dec 19 Filed by: Brandt Peter C.
Low
Report
Form 4 IN8BIO, INC. For: Dec 19 Filed by: Brandt Peter C.
12/23
04:15 pm
inab
Form 4 IN8BIO, INC. For: Dec 19 Filed by: McCall Patrick
Low
Report
Form 4 IN8BIO, INC. For: Dec 19 Filed by: McCall Patrick
12/23
04:15 pm
inab
Form 4 IN8BIO, INC. For: Dec 19 Filed by: Epperly Corinne
Low
Report
Form 4 IN8BIO, INC. For: Dec 19 Filed by: Epperly Corinne
12/23
04:15 pm
inab
Form 4 IN8BIO, INC. For: Dec 19 Filed by: Graff Jeremy R.
Low
Report
Form 4 IN8BIO, INC. For: Dec 19 Filed by: Graff Jeremy R.
12/23
04:15 pm
inab
Form 4 IN8BIO, INC. For: Dec 19 Filed by: Greenwood Luba
Low
Report
Form 4 IN8BIO, INC. For: Dec 19 Filed by: Greenwood Luba
12/23
04:15 pm
inab
Form 4 IN8BIO, INC. For: Dec 19 Filed by: Rochlin Kate
Low
Report
Form 4 IN8BIO, INC. For: Dec 19 Filed by: Rochlin Kate
Stock Stats
| News Stats | |
|---|---|
| All News | |
| News Wires | |
| Media Monitoring | |
| SEC Edgar Filings | |
| Upgrades | |
| Downgrades | |
| Initiated | |
| Reiterated | |
| Last Earnings | |
| Last Earnings EPS | |
| Next Earnings | |
| Order Stats |
|---|
| Sub-Penny |
|
|
| Odd lot |
|
|
| Avg. bid-ask spread |
|
|
| Avg. bid-ask size |
|
|
| Shares at ask/bid |
|
|
| Off exchange |
|
|
Main News & Impact Reports
TOP News Gainers
TOP News Decliners
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below: